Compare Abeona Therapeutics Inc (ABEO) vs abrdn Income Credit Strategies Fund (ACP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs abrdn Income Credit Strategies Fund — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while abrdn Income Credit Strategies Fund trades at $5.11 (market cap $641.16M). The key difference: abrdn Income Credit Strategies Fund is the larger of the two by market cap, and abrdn Income Credit Strategies Fund pays a 18.2% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | ACP | |
|---|---|---|
Market Cap | $421.19M | $641.16M |
Sector | Health | Financials |
52-Week High | $7.45 | $5.98 |
52-Week Low | $4.17 | $5.01 |
Enterprise Value | $276.10M | — |
Dividend Yield | — | 18.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Read more on ACP →
